Sign in

CIK 0001645460 · Non-accelerated filer<br>Smaller reporting company

Cue Biopharma, Inc.

Sign in to watch
Ticker
CUE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
473324577
Phone
617-949-2680
Business address
100 CHESTNUT STREET, SUITE 300, SOMERVILLE, MA, 02143
Former names
Imagen Biopharma, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$389,304
in 3 filings

Net −$389,304. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Lin Shao-Lee −$305K Chief Executive Officer sold 2% of stake
  2. Ray Sumita −$52K Chief Legal Compliance Officer sold 2% of stake
  3. Meluzio Michael Vincent −$32K VP, Prin. Accounting Officer sold 2% of stake

Reading 20 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-10-03 Suri Anish President and CSO Grant or award · Stock Option (right to buy) +400,000 $7.53 $3.0M 400,000
2019-10-03 Suri Anish President and CSO Grant or award · Restricted Stock Units +100,000 0
2019-06-21 PASSERI DANIEL R CEO and President Purchase +1,377 $7.26 $10K 51,977
2019-06-10 Sandercock Colin SVP, General Counsel and Sec Purchase +15,025 $7.90 $119K 17,125
2019-06-10 Sandercock Colin SVP, General Counsel and Sec Purchase +14,938 $7.93 $118K 16,938
2019-06-07 Sandercock Colin SVP, General Counsel and Sec Purchase +100 $7.35 $735 2,100
2019-06-06 Sandercock Colin SVP, General Counsel and Sec Purchase +2,000 $7.10 $14K 2,000
2019-06-06 PASSERI DANIEL R CEO and President Purchase +3,000 $6.90 $21K 50,600
2019-03-06 PASSERI DANIEL R CEO and President Grant or award · Stock Option (right to buy) +125,000 125,000
2019-03-06 PASSERI DANIEL R CEO and President Grant or award · Stock Option (right to buy) +100,000 100,000
2019-03-06 Suri Anish Chief Scientific Officer Grant or award · Stock Option (right to buy) +150,000 150,000
2019-03-06 Suri Anish Chief Scientific Officer Grant or award · Stock Option (right to buy) +100,000 100,000
2019-03-06 Mancilla Bethany SVP and Chief Business Officer Grant or award · Stock Option (right to buy) +65,000 65,000
2019-03-06 Mancilla Bethany SVP and Chief Business Officer Grant or award · Stock Option (right to buy) +100,000 100,000
2019-03-06 Sandercock Colin SVP, General Counsel and Sec Grant or award · Stock Option (right to buy) +50,000 50,000
2019-03-06 Sandercock Colin SVP, General Counsel and Sec Grant or award · Stock Option (right to buy) +100,000 100,000
2019-03-06 Millar Kerri-Ann VP-Finance Grant or award · Stock Option (right to buy) +30,000 30,000
2019-01-02 Simon Barry J. Director Grant or award · Stock Option (right to buy) +9,600 9,600
2019-01-02 Morich Frank Director Grant or award · Stock Option (right to buy) +8,000 8,000
2019-01-02 MCKNIGHT STEVEN L Director Grant or award · Stock Option (right to buy) +8,000 8,000

Page 15 of 17 · 323 trades